Does EVOLOCUMAB Cause Product temperature excursion issue? 70 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 70 reports of Product temperature excursion issue have been filed in association with EVOLOCUMAB (REPATHA). This represents 0.1% of all adverse event reports for EVOLOCUMAB.
70
Reports of Product temperature excursion issue with EVOLOCUMAB
0.1%
of all EVOLOCUMAB reports
0
Deaths
1
Hospitalizations
How Dangerous Is Product temperature excursion issue From EVOLOCUMAB?
Of the 70 reports, 1 (1.4%) required hospitalization.
Is Product temperature excursion issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EVOLOCUMAB. However, 70 reports have been filed with the FAERS database.
What Other Side Effects Does EVOLOCUMAB Cause?
Device difficult to use (31,807)
Drug dose omission by device (23,957)
Wrong technique in product usage process (21,664)
Accidental exposure to product (16,160)
Injection site pain (9,988)
Product storage error (6,606)
Back pain (5,254)
Myalgia (5,061)
Drug dose omission (4,914)
Injection site bruising (4,409)
What Other Drugs Cause Product temperature excursion issue?
SECUKINUMAB (219)
ADALIMUMAB (190)
ABATACEPT (158)
OFATUMUMAB (157)
INSULIN GLARGINE (130)
TOCILIZUMAB (129)
VEDOLIZUMAB (111)
ONABOTULINUMTOXINA (96)
BRENTUXIMAB VEDOTIN (94)
RISANKIZUMAB (88)
Which EVOLOCUMAB Alternatives Have Lower Product temperature excursion issue Risk?
EVOLOCUMAB vs EXELON
EVOLOCUMAB vs EXEMESTANE
EVOLOCUMAB vs EXENATIDE
EVOLOCUMAB vs EXFORGE
EVOLOCUMAB vs EXJADE